1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Catalog No.: 
ACSXHB816
CAS No.: 
2213398-77-5
Molecular Formula: 
C21H21N5O
Molecular Weight: 
359.43
1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$63.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
IUPAC Name1-butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Molecular FormulaC21H21N5O
Molecular Weight359.43
SMILESNC1=C2C(N(CCCC)N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)=NC=N1
InChI KeyZBUPBVVCOFBVDP-UHFFFAOYSA-N
Synonym1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 1-butyl-3-(4-phenoxyphenyl)-;Ibrutinib Impurity IMDJ;1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (Ibrutinib Impurity);Ibrutinib Impurity 24/1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;6β-Hydroxynaloxone
CAS No.2213398-77-5

Synthetic Route by SureRoute

1. ACSXHB816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQEIG608 route compound structure diagram
    ACQEIG60851067-38-0In Stock
  4. Then
  5. ACSXHB816 route product structure diagram
    ACSXHB8162213398-77-5
Inquiry

2. ACSXHB816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSCFY678 route compound structure diagram
    ACSCFY678330786-24-8In Stock
  4. Then
  5. ACSXHB816 route product structure diagram
    ACSXHB8162213398-77-5
Inquiry

3. ACSXHB816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSXHB816 route product structure diagram
    ACSXHB8162213398-77-5
Inquiry

Comments (0)